COMP <GO>
ECG vs MA // ENTERPRISE SCALE & MARKET CAP
Everus Construction Group Inc. (NYSE) VS. Mastercard Incorporated (NYSE) • 15-METRIC TALLY: ECG 4
— MA 11
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MA
LAST: $102.63 (-5.02%) • MKT CAP: $5.52B
market-cap
$5.52B
LAST: $638.01 (+0.36%) • MKT CAP: $556.88B
market-cap
$556.88B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ECG VS. MA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ECG | MA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 12.10% | 41.00% | -28.90 | MA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 30.40% | 33.50% | -3.10 | MA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.7x | 29.2x | -15.50 | ECG | /valuation <GO> |
| Free Cash Flow Yield | -0.21% | 3.08% | -3.29 | MA | /fcf-yield <GO> |
| Operating Margin | 7.10% | 57.60% | -50.50 | MA | /operating-margins <GO> |
| Net Profit Margin | 5.40% | 45.60% | -40.20 | MA | /net-margins <GO> |
| Revenue Growth (YoY) | 31.50% | 16.40% | +15.10 | ECG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | MA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.47 | 11.17 | -4.70 | MA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | MA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 6.60% | +0.70 | MA | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.3 | 70.6 | -30.33 | MA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.13 | 0.90 | +0.23 | ECG | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.9x | 31.2x | -8.30 | ECG | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $5.52B | $556.88B | -$551.36B | MA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ECG REV | MA REV | ECG GROSS % | MA GROSS % | ECG FCF | MA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.75B | $32.79B | 12.1% | 44.0% | -$11.7M | $17.16B |
| FY 2024 | $2.85B | $28.17B | 11.9% | 44.0% | $35.1M | $14.31B |
| FY 2023 | $2.85B | $25.10B | 44.0% | 44.0% | $42.9M | $10.85B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ECG // BETA 1.13
MA // BETA 0.90